Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin - Wikidata - wikimedia - TriplyDB

Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin

Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin

http://www.wikidata.org/entity/Q28376449

about

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model Noninvasive diagnosis of chemotherapy related cardiotoxicity Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors Cardiac biomarkers in HIV-exposed uninfected children.The utility of serum biomarkers to detect myocardial alterations induced by Imatinib in rats.Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy.Anthracycline cardiotoxicity: from bench to bedside.Cardiovascular effects in childhood cancer survivors treated with anthracyclines.Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.Serum troponins as biomarkers of drug-induced cardiac toxicity.Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation Cardiac toxicity of high-dose chemotherapy.Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management.Early change in left atrial function in patients treated with anthracyclines assessed by real-time three-dimensional echocardiography.Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial Identifying cancer patients at risk for cardiotoxicity.Heart failure and chemotherapeutic agents.Anthracycline or trastuzumab-related cardiotoxicity: do we have a predictive biomarker?Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancer.Doxorubicin-induced chronic dilated cardiomyopathy-the apoptosis hypothesis revisited.MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.Can we find a good biochemical marker of early cardiotoxicity in children treated with haematopoietic stem cell transplantation?Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity.Decitabine induced transient cardiomyopathy: a case report An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity.A multifaceted evaluation of imatinib-induced cardiotoxicity in the rat.Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide.Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin.Cardiac damage in rodents after exposure to bis(2-chloroethoxy)methane.Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model.Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury.Sex-related differences in mast cell activity and doxorubicin toxicity: a study in spontaneously hypertensive rats.Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.Anthracycline cardiotoxicity: the importance of horizontally integrating pre-clinical and clinical research.

P2860

Q24628695-DB05F21C-5025-4DCC-A80A-B7D8C1F75C69 Q27007849-A0A6C67C-634B-43DD-9043-613D0B00A58B Q27027354-9893191C-A333-44ED-B8CE-1730A5686C74 Q27310238-DD43A073-27B4-4C9C-B2EA-78468CEE7F37 Q28484922-D9F4BABB-1EB9-4928-A006-F5754B9CBE0A Q28541327-0132AFA2-D7F8-4125-BE73-1051CF9D73BA Q30461444-274D6512-3399-4C7F-B5FE-999EA85D3867 Q33816471-3EDDF386-0AC3-41D2-AB9B-EDE259684F30 Q33948488-444B3426-15C2-4BF6-85DC-18B0BE06DED3 Q34081675-F8B56078-F6A6-4D31-B598-19EE6386016D Q34292469-1C3A260B-E50F-47DA-BA78-2D01A0B190C8 Q34466688-A9F97B82-E37E-4177-86F6-27BFD5FCC601 Q34477415-533D3FE5-A721-4952-AAE5-BE1CE0AE0EDE Q34572109-B29CCE2C-656D-4A56-B978-939358C5B190 Q35588736-F8FF6595-096C-4A7D-A0B9-974E1A4EAD09 Q35624619-EF6782A2-D56F-46BC-9A09-AA46292FB15D Q35800366-D1EA2AA7-8B5E-4772-B22E-21E2962F047E Q35949084-84DF8F97-7C4F-45C8-A3EF-120B5F827E71 Q36828128-D57B6960-51C1-4AF4-89C7-8B6C0F88E92C Q36872695-58CB5897-152C-49A7-9EA3-2FB2204A5969 Q37129069-703B9B42-4EBA-48D5-A007-D7E86FB5F1F0 Q38551772-CCDD470C-0E05-4BD3-8376-E958630A2875 Q38559133-6A89E361-2757-4AAD-B5FE-272B110E9BF3 Q38727423-5CD24BBB-AEFB-4D56-B8D5-77CA183B4411 Q38873927-2FCDE053-2C5E-406F-A804-5D7641B927E5 Q39033784-34AE438E-7FBC-499C-9EC2-9E3403ACBEFF Q40026732-4DB07327-49DC-4A1A-9039-D80F2610648C Q41030597-2F29DBD1-18C6-456D-9EAB-6BFD380F0BBC Q41943341-FC7C5DBC-6CBC-4CEE-BC71-5D72C961AE10 Q42430693-29BC7A9D-D92C-4447-BFB3-826010ED31BE Q42706225-9415BBBA-7AD5-49F0-8EB0-BD9E9983AA28 Q42726669-BE793087-730E-449E-9823-11FCF14821A0 Q43728171-7906198C-5209-4D1E-B41D-EEF9A0718F67 Q44749321-9ACB1EE8-4D56-42F8-8A35-0000D1FD6AF2 Q44942444-C07C9A5F-0CF4-4282-9515-678A58D84544 Q46309853-FF95A4D8-602E-4EE8-AB74-D56C60CA681B Q46694551-85135986-EFC2-4A05-9192-86E0D7B698F8 Q46797043-B58BBFA5-ECD8-4088-9716-1CB0FC1ABAF4 Q48402822-BAE9388E-E05A-4282-AE9A-0FC25B118CB1 Q49617830-63BF52B8-C179-4EBA-88F8-E8CBD4EBF808

P2860

Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin

http://www.wikidata.org/entity/Q28376449

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

Correlation between serum leve ...... yopathy induced by doxorubicin

@ast

Correlation between serum leve ...... yopathy induced by doxorubicin

@en

Correlation between serum leve ...... yopathy induced by doxorubicin

@nl

type

label

Correlation between serum leve ...... yopathy induced by doxorubicin

@ast

Correlation between serum leve ...... yopathy induced by doxorubicin

@en

Correlation between serum leve ...... yopathy induced by doxorubicin

@nl

prefLabel

Correlation between serum leve ...... yopathy induced by doxorubicin

@ast

Correlation between serum leve ...... yopathy induced by doxorubicin

@en

Correlation between serum leve ...... yopathy induced by doxorubicin

@nl

P1433

Q28376449-450A26FE-422F-432F-AD16-19D5F52AF096

P1476

Q28376449-6D3B3CD5-E787-4DDA-A9BF-2D0379315B93

P2093

Q28376449-32952A41-9A7D-4E94-BE7F-67D09FE8F4C2

Q28376449-66A94D7D-B130-494A-BDBD-177882C48D72

Q28376449-81B102EA-81F8-4E05-92A6-AACF463BEBD9

Q28376449-91F9AA0B-3B6C-48A9-B061-B378C691665F

Q28376449-9EDD5342-A79C-4218-8B26-F334C52CC513

Q28376449-BD370558-42C0-4439-B371-3C9B685CA0BB

Q28376449-C1372AD2-43EF-4426-BB35-3D4DB2443EDA

Q28376449-E5818C07-CFD9-44FE-94CC-44CA965BC597

P304

Q28376449-26BA8566-7498-4286-BCF5-74895D631506

P31

Q28376449-D30E6A90-4FA9-4887-BB37-C1B24FBAD985

P3181

Q28376449-FE327385-F1F1-4B91-AB98-726781CA1EEB

P356

Q28376449-7A49CD40-7F9C-4471-9E54-F490B20C9D3E

P407

Q28376449-1887FA5A-A014-4E36-94F5-75993150E12A

P433

Q28376449-52D1DEF6-EA4E-4B47-9D0B-3AD10A8D50C0

P478

Q28376449-0ABE42AE-9867-4070-9338-3824B2EA5D27

P577

Q28376449-2112AC29-5D85-4C66-A1F0-7F78A83FC3D5

P698

Q28376449-CFB4E91A-10A8-4E2E-B063-966D2A01A925

P3181

P356

JCO.1999.17.7.2237

P1433

Journal of Clinical Oncology

P1476

Correlation between serum leve ...... yopathy induced by doxorubicin

@en

P2093

D Chadwick

http://www.w3.org/2001/XMLSchema#string

E H Herman

http://www.w3.org/2001/XMLSchema#string

J Zhang

http://www.w3.org/2001/XMLSchema#string

K Takeda

http://www.w3.org/2001/XMLSchema#string

N Rifai

http://www.w3.org/2001/XMLSchema#string

S E Lipshultz

http://www.w3.org/2001/XMLSchema#string

V J Ferrans

http://www.w3.org/2001/XMLSchema#string

Z X Yu

http://www.w3.org/2001/XMLSchema#string

P304

2237-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1839041

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.1999.17.7.2237

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10561281

http://www.w3.org/2001/XMLSchema#string